Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03923101 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Homburg Keratoconus Center (HKC)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jan 1, 2032 to Jan 1, 2036v6
  2. Enrollment target: 1200 to 5000
    • Primary completion date: Jan 1, 2028 to Jan 1, 2032
    • Site contact updated
    • Publications: 5 to 9
    v5
  3. Primary completion date: Jan 1, 2025 to Jan 1, 2028
    • Study completion date: Jan 1, 2030 to Jan 1, 2032
    v4
  4. Primary completion date: Jan 1, 2023 to Jan 1, 2025v3
  5. Primary completion date: Jan 1, 2021 to Jan 1, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC). The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.
Trial Details
NCT Number NCT03923101
Lead Sponsor Universität des Saarlandes
Conditions
(from sponsor)		 Keratoconus
Related terms Keratoconus
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov